Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes

British Journal of Cancer

Volumn 85, Issue 9, 2001, Pages 1340-1346

  Wascher, R A ^a   Bostick, P J ^a   Huynh, K T ^a   Turner, R ^a   Qi, K ^a   Giuliano, A E ^a   Hoon, D S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; MAGE A3; Micrometastases; RT PCR; Sentinel lymph node

Indexed keywords

MELANOMA ANTIGEN 3; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SOUTHERN BLOTTING;

ADULT; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TUMOR CELLS, CULTURED;

EID: 0035798455     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.2079     Document Type: Article

References (52)

1. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma
2. Pleomorphic lobular carcinoma of the breast: Clinicopathologic features of 12 cases
3. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
4. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer
5. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR
6. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients
7. Expression of MUC-1 epitopes on normal bone marrow: Implications for the detection of micrometastatic tumor cells
8. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction
9. Benign transport of breast epithelium into axillary lymph nodes after biopsy
10. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas
11. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction
12. An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR
13. Prognostic factors in breast cancer
14. Expression of MAGE and BAGE genes in Japanese breast cancers
15. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
16. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
17. Improved axillary staging of breast cancer with sentinel lymphadenectomy
18. Sentinel lymphadenectomy in breast cancer
19. College of American pathologists conference XXXV: Solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation
20. Karnofsky Memorial Lecture: Natural history of small breast cancers
21. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction
22. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
23. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen
24. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction
25. Prognostic importance of occult axillary lymph node micrometastases from breast cancers
26. Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells
27. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis
28. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasiaductal type - Benign and malignant intraductal proliferations
29. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction
30. Expression of MAGE genes in human colorectal carcinoma
31. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer
32. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification
33. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors
34. Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: Implications for MAGE immunotherapy
35. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine
36. Detection and clinical importance of micrometastatic disease
37. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast
38. Metastasis of unknown origin: The role of fine-needle aspiration cytology
39. Patterns of chromosomal imbalances in invasive breast cancer
40. Expression of the MAGE gene family in primary and metastatic human breast cancer: Implications for tumor antigen-specific immunotherapy
41. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction
42. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
43. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
44. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma
45. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
46. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging
47. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
48. A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma
49. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma
50. Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer
51. Benign proliferative nipple duct lesions frequently contain CAM 5.2 and anti-cytokeratin 7 immunoreactive cells in the overlying epidermis
52. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow